---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-349193"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2026-08-13T20:11:08+00:00"
generated_at: "2026-08-13T20:13:24.929876+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Invivyd Q2 2026 revenue up 21% to $14.3M; net loss widens to $44.4M; PEMGARDA EUA termination notice

## Summary
- Q2 2026 PEMGARDA net product revenue $14.3M, up 21% YoY from $11.8M.
- Net loss $44.4M vs $14.7M; EPS -$0.14 vs -$0.12; R&D spend $29.4M vs $9.6M.
- Cash $160.1M; runway through DECLARATION data readout and potential VYD2311 launch.
- Received 12-month notice of PEMGARDA EUA termination in July 2026; in dialogue with FDA.
- DECLARATION enrollment complete, top-line data later Q3 2026; LIBERTY fully dosed, top-line late Q3 2026.

## SEC filing metadata
- accession: 0001193125-26-349193
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2026-08-13T20:11:08+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000119312526349193/0001193125-26-349193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000119312526349193/ivvd-20260813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-349193
- JSON: https://secwatch.observer/filing/0001193125-26-349193.json
- Plain text: https://secwatch.observer/filing/0001193125-26-349193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.